FDA to supervise three Tylenol plants

March 11, 2011 at 2:01 PM   |   Comments

WASHINGTON, March 11 (UPI) -- The U.S. government announced it is taking over three Tylenol plants following recalls and a criminal investigation into safety issues at the factories.

The Food and Drug Administration and the Justice Department took action against Tylenol maker McNeil PPC and two of its executives --- its vice president of quality and its vice president of operations for over-the-counter products -- for failing to comply with federally mandated manufacturing practices, CNN reported Friday.

McNeil, a division of Johnson & Johnson, said it had agreed to put the plants under FDA supervision.

The plants are in Las Piedras, Puerto Rico, Fort Washington, Pa., and Lancaster, Pa.

The "consent decree" agreement requires McNeil to adhere to a strict timetable to bring those facilities into compliance.

"This is a strong, but necessary, step to ensure that the products manufactured by this company meet federal standards for quality, safety and purity," Deborah Autor, director of the FDA Office of Compliance, said.

McNeil's drug-making operations have been under intense scrutiny in the past year after successive recalls in 2010 of over-the-counter pain and cold medicines such as Tylenol, Benadryl and Motrin produced at the three facilities.

© 2011 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
2014: The Year in Music [PHOTOS]

2014: The Year in Music [PHOTOS]

Most Popular
Hershey's new logo launched, compared to emoji poop
Brazil Air Force, Saab discuss Gripen procurement deal
The 'Home of the Whopper' to keep headquarters in U.S.
Abercrombie & Fitch axes logos after years of declining sales and bad press
Google completes first phase of testing drone delivery system
Trending News